Management of relapse after allo-SCT for AML and the role of second transplantation
Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF
Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia
Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
Early lymphocyte recovery after allogeneic hematopoietic SCT is associated with significant GVL effect in pediatric ALL but not acute myelogenous leukemia—Update study
Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions
Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD
Chronic GVHD manifesting as parotitis after allogeneic hematopoietic SCT
Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma
Ethmoiditis-associated apex syndrome may result in temporary blindness after allo-SCT
Detection of extra-medullary relapse of acute lymphoblastic leukemia by radiographic imaging following allogeneic hematopoietic SCT